Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients

BACKGROUND: High risk, unfavorable classical Hodgkin lymphoma (cHL) includes those patients with primary refractory or early relapse, and progressive disease. To improve the availability of biomarkers for this group of patients, we investigated both tumor biopsies and peripheral blood leukocytes (PB...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gharbaran, Rajendra, Goy, Andre, Tanaka, Takemi, Park, Jongwhan, Kim, Chris, Hasan, Nafis, Vemulapalli, Swathi, Sarojini, Sreeja, Tuluc, Madalina, Nalley, Kip, Bhattacharyya, Pritish, Pecora, Andrew, Suh, K Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3766006/
https://ncbi.nlm.nih.gov/pubmed/23988031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-62
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados